Why StoneX Group Inc. (SNEX) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
More News
Zacks.com featured highlights include BrightSpring Health Services, Dycom Industries, StoneX and Orion Group
BrightSpring Health Services, Dycom Industries, StoneX and Orion Group are highlighted for rising cash flow and improving earnings estimates.
Zacks
4 Stocks Worth Buying Now on Solid Cash Flow Growth
BrightSpring, Dycom, StoneX and Orion stand out as buy-worthy stocks, backed by rising cash flows and upward earnings estimate revisions.
Zacks
StoneX Group (SNEX) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, StoneX Group (SNEX) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Zacks
Zacks.com featured highlights Vishay Precision, ASE Technology, StoneX, Hooker and Helios
Vishay Precision, ASE Technology, StoneX, Hooker and Helios have been highlighted in this Screen of The Week article.
Zacks
Here's Why StoneX Group Inc. (SNEX) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
5 Stocks With Recent Price Strength to Maximize Your Gains
VPG, ASX, SNEX, HOFT and HLIO surge on strong momentum, with sharp price gains and rising earnings estimates signaling potential for continued upside.
Zacks
StoneX Group President Sold $1.19M In Company Stock
read more...
Benzinga
Is SNEX Stock Worth Buying After Its Sharp Run and Richer Valuation?
StoneX's record results and acquisition gains support the bull case, but its sharp rally and richer valuation make clean execution crucial.
Zacks
StoneX Is Tapping AI, Trading Volatility and Global Expansion
SNEX is leveraging AI, trading volatility and acquisitions to broaden its platform, but margin pressure and premium valuation remain key risks.